Literature DB >> 30730134

Surface-Engineered Design of Efficient Luminescent Europium(III) Complex-Based Hydroxyapatite Nanocrystals for Rapid HeLa Cancer Cell Imaging.

Takuya Kataoka1, Shigeaki Abe2, Motohiro Tagaya1.   

Abstract

We synthesized hydroxyapatite nanocrystals under the existence of tris(2,2,6,6-tetramethyl-3,5-heptanedionato)europium(III) (EuTH) complex to form inorganic/organic hybrid nanocrystal (EHA). Then, the folic acid derivative (folate N-hydroxysuccinimidyl ester (FA-NHS)) as the targeting ligand for the HeLa cancer cells was immobilized on the EHA by the mediation of both 3-aminopropyltriethoxysilane and methyltriethoxysilane molecules. Here, we investigated the photofunctions based on the interfacial interactions between the FA-NHS and EHA nanohybrids for preparing the novel bioimaging nanomaterials. As a result, the photofunctions could be changed by the FA-NHS molecular occupancy on the EHA. When the molecular occupancy ratio to the EHA surfaces is at around 3-5%, the intense luminescence from the f-f transition of the Eu3+ ions as well as the charge transfer between the EuTH-FA-NHS was observed to exhibit higher quantum efficiency. Moreover, effective dispersibility in phosphate-buffered saline was confirmed with immobilizing the positively charged FA-NHS. The cytotoxicity against the HeLa cells was also evaluated to verify whether the nanohybrids can be the candidate for cell imaging. The affinity and noncytotoxicity between the FA-NHS-immobilized EHA nanohybrids and cells were monitored for 3 days. Red luminescence from the cells could be observed, and the labels with following the cellular shapes were achieved by an additional culture time of 1 h after injecting the FA-NHS-immobilized EHA nanohybrids to the spheres, indicating the rapid bioimaging process. Therefore, this is the first successful report to describe the synthesis of inorganic-organic nanohybrid systems for controlling the EuTH-FA-NHS interactions. The photofunction of the interfacial interactions was successfully designed to provide "efficient luminescent ability" as well as "rapid targeting to the cancer cells" in one particle.

Entities:  

Keywords:  bioimaging particles; cancer cell imaging; europium(III) complex; hydroxyapatite nanocrystals; inorganic−organic nanohybrid systems; luminescent nanomaterials; photofunctional interfaces

Mesh:

Substances:

Year:  2019        PMID: 30730134     DOI: 10.1021/acsami.8b22740

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  6 in total

Review 1.  Recent Advances in Luminescence Imaging of Biological Systems Using Lanthanide(III) Luminescent Complexes.

Authors:  Jorge H S K Monteiro
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

2.  Small protein sequences can induce cellular uptake of complex nanohybrids.

Authors:  Jan-Philip Merkl; Malak Safi; Christian Schmidtke; Fadi Aldeek; Johannes Ostermann; Tatiana Domitrovic; Sebastian Gärtner; John E Johnson; Horst Weller; Hedi Mattoussi
Journal:  Beilstein J Nanotechnol       Date:  2019-12-12       Impact factor: 3.649

3.  Red-Emitting Hybrid Based on Eu3+-dbm Complex Anchored on Silica Nanoparticles Surface by Carboxylic Acid for Biomarker Application.

Authors:  João A O Santos; Alessandra M G Mutti; Airton G Bispo-Jr; Ana M Pires; Sergio A M Lima
Journal:  Materials (Basel)       Date:  2020-12-02       Impact factor: 3.623

Review 4.  The Use of Upconversion Nanoparticles in Prostate Cancer Photodynamic Therapy.

Authors:  Michał Osuchowski; Filip Osuchowski; Wojciech Latos; Aleksandra Kawczyk-Krupka
Journal:  Life (Basel)       Date:  2021-04-19

Review 5.  Hydroxyapatite Nanoparticles for Improved Cancer Theranostics.

Authors:  Saeid Kargozar; Sahar Mollazadeh; Farzad Kermani; Thomas J Webster; Simin Nazarnezhad; Sepideh Hamzehlou; Francesco Baino
Journal:  J Funct Biomater       Date:  2022-07-20

Review 6.  Hydroxyapatite Biobased Materials for Treatment and Diagnosis of Cancer.

Authors:  María Del Carmen De Lama-Odría; Luis J Del Valle; Jordi Puiggalí
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.